females to follow finalist
RISING STAR IN ENTREPRENEURSHIP
Aisling Foley
CEO and Co-Founder
ExCulture
About Aisling Foley
Aisling Foley co-founded ExCulture in 2022,
motivated by the potential of ExCulture’s novel bioprocess to not only have a
positive impact on patient outcomes but also to contribute to a more
future-proof supply chain for life-saving medicines. Her academic background
focused on environmental and sustainable chemistry at University College Dublin
(BSc), the University of Virginia (international exchange), and Leiden
University (MSc). Aisling grew up on a farm in Ireland, and before undertaking
the role of CEO at ExCulture, she gained experience through internships in
Process Development and Commercialisation at MSD and in Project Management
(Finance/HR) at AkzoNobel.
About ExCulture
ExCulture, a biotech spin-out of Technical University Delft, the Netherlands, is developing a next-gen, animal-free alternative to heparin using its patent-pending microbial bioprocess. Used in millions of surgeries and treatments each year, heparin is a critical anticoagulant (blood thinner) on the WHO’s list of essential medicines. However, its current production method relies heavily on animal sources, as it is produced from the mucosal lining of pig intestines. This introduces safety risks, ethical concerns, and global supply vulnerabilities. ExCulture’s next-gen heparin offers a more sustainable, secure and ethically sound alternative to heparin.
ExCulture, a biotech spin-out of Technical University Delft, the Netherlands, is developing a next-gen, animal-free alternative to heparin using its patent-pending microbial bioprocess. Used in millions of surgeries and treatments each year, heparin is a critical anticoagulant (blood thinner) on the WHO’s list of essential medicines. However, its current production method relies heavily on animal sources, as it is produced from the mucosal lining of pig intestines. This introduces safety risks, ethical concerns, and global supply vulnerabilities. ExCulture’s next-gen heparin offers a more sustainable, secure and ethically sound alternative to heparin.
| Powered by: Hyphen Projects BV | Connect with us | Join TOPX | |||
| Privacy Policy Terms & Conditions Chamber of Commerce: 32110979 VAT no: NL8184.34.491.B01 | | |
© Copyright 2020 by Hyphen Projects